New Trial Frees Type 1 Diabetes Patients from Daily Insulin Jabs
A groundbreaking T1D trial used donor islet cells and Tegoprubart to free patients from daily insulin jabs. Participants stayed insulin-free for up to 14 months.
MedicalTrial
Read More